Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.74 Delayed Data As of 4:00pm ET |  +0.085 / +3.20%Today’s Change | 1.24 Today|||52-Week Range 9.02 | -22.82% Year-to-Date |
Latest ABUS News | Press Releases
| Arbutus Biopharma (ABUS) Q1 2021 Earnings Call Transcript May 06 / MotleyFool.com - Paid Partner Content | Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates May 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.66 |
| Today’s open | 2.50 |
| Day’s range | 2.46 - 2.80 |
| Volume | 120,421 |
| Average volume (3 months) | 2,268,472 |
| Market cap | $270.9M |
Data as of 4:00pm ET, 05/11/2021
Growth & Valuation
| Earnings growth (last year) | +65.36% |
| Earnings growth (this year) | +17.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +15.02% |
| P/E ratio | NM |
| Price/Sales | 38.94 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EYPTEyePoint Pharmaceuti... | +0.03 | +0.34% |
| INFIInfinity Pharmaceuti... | +0.01 | +0.34% |
| MBIOMustang Bio Inc | +0.06 | +1.90% |
| ONCTOncternal Therapeuti... | -0.02 | -0.38% |
Data as of 3:59pm ET, 05/11/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$63.7M |
| Net profit margin | -921.97% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
